Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 195

Sort by

Sort Order Select

Journal Articles

Targeting pediatric leukemia-propagating cells with anti-CD200 antibody therapy

Paraskevi Diamanti, Charlotte V. Cox, Benjamin C. Ede, Robert A. Uger, John P. Moppett, Allison Blair

Blood Adv (2021) 5 (18): 3694–3708.

https://doi.org/10.1182/bloodadvances.2020003534

Published: 2021

Includes: Supplemental data

Journal Articles

American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation

Julie Kanter, Robert I. Liem, Françoise Bernaudin, Javier Bolaños-Meade, Courtney D. Fitzhugh, Jane S. Hankins, M. Hassan Murad, Julie A. Panepinto, Damiano Rondelli, Shalini Shenoy, John Wagner, Mark C. Walters, Teonna Woolford, Joerg J. Meerpohl, John Tisdale

Blood Adv (2021) 5 (18): 3668–3689.

https://doi.org/10.1182/bloodadvances.2021004394

Published: 2021

Includes: Supplemental data

Journal Articles

An irradiated marrow niche reveals a small noncollagenous protein mediator of homing, dermatopontin

Ashley C. Kramer, Yuliana Astuti, Alexis Elfstrum, Michael J. Lehrke, Jakub Tolar, Bruce R. Blazar, Amanda L. Blake, Mandy E. Taisto, Justin W. Furcich, Erin E. Nolan, Wilaiwan W. Durose, Beau R. Webber, Athena Geisness, David K. Wood, Troy C. Lund

Blood Adv (2021) 5 (18): 3609–3622.

https://doi.org/10.1182/bloodadvances.2021004475

Published: 2021

Includes: Supplemental data

Journal Articles

Autologous and allogeneic hematopoietic cell transplantation for diffuse large B-cell lymphoma–type Richter syndrome

Blood Adv (2021) 5 (18): 3528–3539.

https://doi.org/10.1182/bloodadvances.2021004865

Published: 2021

Includes: Supplemental data

Journal Articles

Pretransplantation EASIX predicts intensive care unit admission in allogeneic hematopoietic cell transplantation

Marta Peña, Maria Queralt Salas, Alberto Mussetti, Gabriel Moreno-Gonzalez, Anna Bosch, Beatriz Patiño, Laura Jiménez, Meriem Kara, Rocío Parody, Anna Sureda

Blood Adv (2021) 5 (17): 3418–3426.

https://doi.org/10.1182/bloodadvances.2021004812

Published: 2021

Includes: Supplemental data

Journal Articles

Enhanced self-renewal of human long-term hematopoietic stem cells by a sulfamoyl benzoate derivative targeting p18 INK4C

Blood Adv (2021) 5 (17): 3362–3372.

https://doi.org/10.1182/bloodadvances.2020004054

Published: 2021

Includes: Supplemental data

Journal Articles

Analysis of biological models to predict clinical outcomes based on HLA-DPB1 disparities in unrelated transplantation

Stéphane Buhler, Helen Baldomero, Sylvie Ferrari-Lacraz, Anne-Claire Mamez, Stavroula Masouridi-Levrat, Dominik Heim, Jörg Halter, Gayathri Nair, Yves Chalandon, Urs Schanz, Tayfun Güngör, Grazia Nicoloso, Jakob R. Passweg, Jean Villard, on behalf of the Swiss Blood Stem Cell Transplantation Group

Blood Adv (2021) 5 (17): 3377–3386.

https://doi.org/10.1182/bloodadvances.2020003998

Published: 2021

Includes: Supplemental data

Journal Articles

Virus-specific T cells for adenovirus infection after stem cell transplantation are highly effective and class II HLA restricted

Blood Adv (2021) 5 (17): 3309–3321.

https://doi.org/10.1182/bloodadvances.2021004456

Published: 2021

Includes: Supplemental data

Journal Articles

Development of immunosuppressive myeloid cells to induce tolerance in solid organ and hematopoietic cell transplant recipients

Blood Adv (2021) 5 (17): 3290–3302.

https://doi.org/10.1182/bloodadvances.2020003669

Published: 2021

Includes: Supplemental data

Journal Articles

Long-term effect of hematopoietic cell transplantation on systemic inflammation in patients with mucopolysaccharidoses

Brigitte T.A. van den Broek, Caroline A. Lindemans, Jaap Jan Boelens, Eveline M. Delemarre, Julia Drylewicz, Nanda Verhoeven-Duif, Peter M. van Hasselt, Stefan Nierkens

Blood Adv (2021) 5 (16): 3092–3101.

https://doi.org/10.1182/bloodadvances.2020003824

Published: 2021

Includes: Supplemental data

Journal Articles

Gowin K, Ballen K, Ahn KW, et al. Survival following allogeneic transplant in patients with myelofibrosis. Blood Adv. 2020;4(9):1965-1973.

Blood Adv (2021) 5 (13): 2751.

https://doi.org/10.1182/bloodadvances.2021005191

Published: 2021

Journal Articles

Approach to the diagnosis of aplastic anemia

Amy E. DeZern, Jane E. Churpek

Blood Adv (2021) 5 (12): 2660–2671.

https://doi.org/10.1182/bloodadvances.2021004345

Published: 2021

Journal Articles

Posttransplant cyclophosphamide as GVHD prophylaxis for peripheral blood stem cell HLA-mismatched unrelated donor transplant

Monzr M. Al Malki, Ni-Chun Tsai, Joycelynne Palmer, Sally Mokhtari, Weimin Tsai, Thai Cao, Haris Ali, Amandeep Salhotra, Shukaib Arslan, Ibrahim Aldoss, Nicole Karras, Chatchada Karanes, Jasmine Zain, Samer Khaled, Anthony Stein, David Snyder, Guido Marcucci, Stephen J. Forman, Ryotaro Nakamura

Blood Adv (2021) 5 (12): 2650–2659.

https://doi.org/10.1182/bloodadvances.2021004192

Published: 2021

Includes: Supplemental data

Journal Articles

Activation of natural killer T cells enhances the function of regulatory T-cell therapy in suppressing murine GVHD

Toshihito Hirai, Po-Yu Lin, Federico Simonetta, Kristina Maas-Bauer, Mustafa Turkoz, Melissa Mavers, Jeanette Baker, Robert S. Negrin

Blood Adv (2021) 5 (11): 2528–2538.

https://doi.org/10.1182/bloodadvances.2020003272

Published: 2021

Includes: Supplemental data

Journal Articles

Posttransplantation MRD monitoring in patients with AML by next-generation sequencing using DTA and non-DTA mutations

Blood Adv (2021) 5 (9): 2294–2304.

https://doi.org/10.1182/bloodadvances.2021004367

Published: 2021

Includes: Supplemental data

Journal Articles

Activity of blinatumomab in lymphoblastic leukemia with impaired T-cell immunity due to congenital immunodeficiency

Sandheeah Ramdeny, Asima Chaudhary, Austen Worth, Sara Ghorashian, Mary Slatter, Su Han Lum, Ajay Vora

Blood Adv (2021) 5 (8): 2153–2155.

https://doi.org/10.1182/bloodadvances.2021004284

Published: 2021

Journal Articles

Transplant-associated thrombotic microangiopathy in pediatric patients: pre-HSCT risk stratification and prophylaxis

Christine S. Higham, Griffin Collins, Kristin A. Shimano, Alexis Melton, Sandhya Kharbanda, Lena E. Winestone, James N. Huang, Jasmeen Dara, Janel R. Long-Boyle, Christopher C. Dvorak

Blood Adv (2021) 5 (8): 2106–2114.

https://doi.org/10.1182/bloodadvances.2020003988

Published: 2021

Includes: Supplemental data

Journal Articles

Microenvironment immune reconstitution patterns correlate with outcomes after autologous transplant in multiple myeloma

Harsh Parmar, Morie Gertz, Emilie Ingrid Anderson, Shaji Kumar, Taxiarchis V. Kourelis

Blood Adv (2021) 5 (7): 1797–1804.

https://doi.org/10.1182/bloodadvances.2020003857

Published: 2021

Includes: Supplemental data

Journal Articles

Oran B, de Lima M, Garcia-Manero G, et al. A phase 3 randomized study of 5-azacitidine maintenance vs observation after transplant in high-risk AML and MDS patients. Blood Adv. 2020;4(21):5580-5588.

Blood Adv (2021) 5 (6): 1755–1756.

https://doi.org/10.1182/bloodadvances.2021004374

Published: 2021

Journal Articles

A prognostic score including mutation profile and clinical features for patients with CMML undergoing stem cell transplantation

Blood Adv (2021) 5 (6): 1760–1769.

https://doi.org/10.1182/bloodadvances.2020003600

Published: 2021

Includes: Supplemental data

NARROW

Targeting pediatric leukemia-propagating cells with anti-CD200 antibody therapy

American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation

An irradiated marrow niche reveals a small noncollagenous protein mediator of homing, dermatopontin

Autologous and allogeneic hematopoietic cell transplantation for diffuse large B-cell lymphoma–type Richter syndrome

Pretransplantation EASIX predicts intensive care unit admission in allogeneic hematopoietic cell transplantation

Enhanced self-renewal of human long-term hematopoietic stem cells by a sulfamoyl benzoate derivative targeting p18 INK4C

Analysis of biological models to predict clinical outcomes based on HLA-DPB1 disparities in unrelated transplantation

Virus-specific T cells for adenovirus infection after stem cell transplantation are highly effective and class II HLA restricted

Development of immunosuppressive myeloid cells to induce tolerance in solid organ and hematopoietic cell transplant recipients

Long-term effect of hematopoietic cell transplantation on systemic inflammation in patients with mucopolysaccharidoses

Gowin K, Ballen K, Ahn KW, et al. Survival following allogeneic transplant in patients with myelofibrosis. Blood Adv. 2020;4(9):1965-1973.

Approach to the diagnosis of aplastic anemia

Posttransplant cyclophosphamide as GVHD prophylaxis for peripheral blood stem cell HLA-mismatched unrelated donor transplant

Activation of natural killer T cells enhances the function of regulatory T-cell therapy in suppressing murine GVHD

Posttransplantation MRD monitoring in patients with AML by next-generation sequencing using DTA and non-DTA mutations

Activity of blinatumomab in lymphoblastic leukemia with impaired T-cell immunity due to congenital immunodeficiency

Transplant-associated thrombotic microangiopathy in pediatric patients: pre-HSCT risk stratification and prophylaxis

Microenvironment immune reconstitution patterns correlate with outcomes after autologous transplant in multiple myeloma

Oran B, de Lima M, Garcia-Manero G, et al. A phase 3 randomized study of 5-azacitidine maintenance vs observation after transplant in high-risk AML and MDS patients. Blood Adv. 2020;4(21):5580-5588.

A prognostic score including mutation profile and clinical features for patients with CMML undergoing stem cell transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only